Michael Brian Bell, the Chief Financial Officer of Guardant Health, Inc., has disclosed several stock transactions in a recent filing. This update is significant as it highlights the financial activities of a key executive within the company.
Background
Guardant Health, Inc. is a prominent company in the medical laboratories sector, specifically classified under SIC 8071. The company is headquartered in Palo Alto, California, and is known for its innovative approaches to cancer diagnostics. Its stock is traded under the symbol GH.
What the Filing Says
The filing, dated October 2, 2026, reveals that Bell engaged in multiple transactions involving common stock and restricted stock units. Specifically, he acquired 2,085 shares, 3,324 shares, and 1,871 shares of common stock on October 1, 2026. Additionally, he reported transactions involving restricted stock units, which included 2,085 shares, 3,324 shares, and 1,871 shares. The filing states:
"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units."
Impact
These transactions may affect various stakeholders, including investors, employees, and the broader market. The disclosure of stock activity by a high-ranking officer like Bell can influence investor perception and provide insights into the company's financial health and executive compensation practices.
What's Next
The filing does not say what happens next.